Your browser doesn't support javascript.
loading
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Ellerhorst, J A; Bedikian, A; Ring, S; Buzaid, A C; Eton, O; Legha, S S.
Affiliation
  • Ellerhorst JA; Department of Melanoma/Sarcoma, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Oncol Rep ; 6(5): 1097-9, 1999.
Article in En | MEDLINE | ID: mdl-10425308
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Melanoma / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Grecia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Melanoma / Antineoplastic Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Grecia